CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended				9 Months Ended
	Sep. 30, 2017		Sep. 30, 2016		Sep. 30, 2017		Sep. 30, 2016
REVENUE:
Dental practice revenue	$ 14,542,690		$ 13,988,133		$ 42,915,170		$ 44,009,444
Capitation revenue	1,001,297		1,166,155		3,068,716		3,461,218
Total Revenue	15,543,987		15,154,288		45,983,886		47,470,662
DIRECT EXPENSES:
Clinical salaries and benefits	9,680,390		9,242,477		28,398,877		28,564,107
Dental supplies	674,402		729,299		1,974,995		2,187,229
Laboratory fees	874,102		869,014		2,687,004		2,648,658
Occupancy	1,637,622		1,591,841		4,840,771		4,712,445
Advertising and marketing	148,257		176,150		485,628		490,227
Depreciation and amortization	869,589		988,031		2,748,083		3,026,164
General and administrative	1,464,120		1,394,284		4,014,757		4,139,482
Total Direct Expenses	15,348,482		14,991,096		45,150,115		45,768,312
Contribution from dental offices	195,505		163,192		833,771		1,702,350
CORPORATE EXPENSES:
General and administrative	908,267	[1]	848,358	[1]	2,879,641	[2]	2,696,123	[2]
Stock grant	0		0		175,000	[3]	0
Depreciation and amortization	38,518		47,114		123,466		165,994
OPERATING LOSS	(751,280)		(732,280)		(2,344,336)		(1,159,767)
OTHER EXPENSE:
Interest expense, net	110,004		70,367		276,842		185,240
LOSS BEFORE INCOME TAXES	(861,284)		(802,647)		(2,621,178)		(1,345,007)
Income tax benefit	(303,719)		(286,131)		(937,281)		(497,653)
NET LOSS	$ (557,565)		$ (516,516)		$ (1,683,897)		$ (847,354)
Net loss per share of Common Stock - Basic (in dollars per share)	$ (0.30)		$ (0.28)		$ (0.90)		$ (0.46)
Net loss per share of Common Stock - Diluted (in dollars per share)	$ (0.30)		$ (0.28)		$ (0.90)		$ (0.46)
Weighted average number of shares of Common Stock and dilutive securities:
Basic (in shares)	1,872,761		1,860,261		1,866,580		1,860,334
Diluted (in shares)	1,872,761		1,860,261		1,866,580		1,860,334

[1] Corporate expense - general and administrative includes $32,309 and $74,031 of stock-based compensation expense pursuant to ASC Topic 718 for the quarters ended September 30, 2016 and 2017, respectively.

[2] Corporate expense - general and administrative includes $123,118 and $160,286 of stock-based compensation expense pursuant to ASC Topic 718 for the nine months ended September 30, 2016 and 2017, respectively.

[3] The Company issued 12,500 shares of Common Stock under a settlement agreement with an activist shareholder group. The shares were valued at $175,000 based on the closing price of the Common Stock on the date of the grant.